Abbott says agreement reached to reopen baby formula plant

Abbott did not immediately detail the terms of the agreement reached with the Food and Drug Administration, which has been investigating safety problems at the Sturgis, Michigan, facility. The consent decree is a binding legal agreement between the company and the federal government.

Associated Press

•

May 16, 2022, 8:53 PM

•

Updated 954 days ago

Share:

KIYC: Retailers crack down on return fraud amid expected $150 billion in holiday returns

3ds ago

0:21

FDA: More than 2 million cans of Jarritos Coconut Water recalled over seal concerns

5ds ago

1:08

The day after Christmas: Hudson Valley shoppers flock to malls for returns

45m ago

1:37

Friday's Mega Millions drawing offers estimated $1.15 billion jackpot

5h ago

1:26

Last-minute holiday shoppers visit The Westchester Mall for the perfect gift

2ds ago

1:11

Last-minute holiday shopping in full swing at Hudson Valley malls

3ds ago

2:03

KIYC: Retailers crack down on return fraud amid expected $150 billion in holiday returns

3ds ago

0:21

FDA: More than 2 million cans of Jarritos Coconut Water recalled over seal concerns

5ds ago

Abbott says agreement reached to reopen baby formula plant

WASHINGTON - Infant formula maker Abbott says it's reached an agreement with U.S. health officials to restart production at its largest domestic factory, a key step toward easing a nationwide shortage tied to the plant’s shutdown earlier this year.

Abbott did not immediately detail the terms of the agreement reached with the Food and Drug Administration, which has been investigating safety problems at the Sturgis, Michigan, facility. The consent decree is a binding legal agreement between the company and the federal government.

After production resumes, Abbott has said it will take at least eight weeks to begin shipping new product to stores.

The Biden administration has come under intense pressure over the last week to do more to ease the shortage of formula that has forced parents of infants to go to significant lengths to feed their children.

Abbott’s plant came under scrutiny earlier this year after four infants became sick with bacterial infections after consuming powdered formula from the Michigan factory. Two of the babies died.

In February, the company halted production and recalled several brands of formula. Those steps squeezed supplies that were already strained by supply chain disruptions and parents stockpiling during COVID-19.